InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,714.00
(
0.18%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.16
(
-0.07%
)
Bitcoin
61,995.30
(
-1.44%
)
Post# of 108192
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oakrock

Send PM Follow Ignore
Followers 0
Posts 783
Boards Moderated 0
Alias Born 03/21/2009

oakrock

Re: ignatiusrielly35 post# 11702

Monday, 01/23/2017 10:33:08 PM

Monday, January 23, 2017 10:33:08 PM

Post# of 108192
So you think AstraZeneca is the suitor because most further along with AXALIMOGENE FILOLISBAC?

http://www.advaxis.com/wp-content/uploads/2017/01/Advaxis-Clinical-Pipeline.pdf

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ADXS News
More ADXS News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!